Patients Slam Bayer, Janssen's Bid To Cut Xarelto Claims
Patients in multidistrict litigation claiming Janssen and Bayer's blood thinner Xarelto caused irreversible bleeding told a Louisiana federal court Tuesday the companies should not be able to escape any claims that...To view the full article, register now.
Already a subscriber? Click here to view full article